The current study found that those prescribed potentially inappropriate medications were actually less likely to revisit the emergency department within 30 days, in contrast to prior work.
A group of researchers has published their study on the impact of potentially inappropriate medications on outcomes among recently hospitalized older patients, sharing their surprising findings that those prescribed potentially inappropriate medications were actually less likely to revisit the emergency department (ED) within 30 days.
The findings contradict previous research suggesting inferior outcomes associated with potentially inappropriate medication use.
Across the more than 7000 Medicare beneficiaries discharged from the ED included in the study, 16% of those not receiving a potentially inappropriate medication—a treatment recommended to be avoided by the Beers criteria—revisited the ED within 30 days compared with 12% of patients who were prescribed at least 1 potentially inappropriate medication. There were no differences in ED revisits within the first 3 days following discharge.
Hospital admissions within 30 days were also less prevalent among patients who received potentially inappropriate medications than those who did not (4% vs 7%).
“Gender and race had no impact on our utilization outcome results. Contrary to previous reports, sex did not predict ED revisits or hospital admission in 3 and 30 days in our study cohort,” highlighted the researchers. “For race, we found non-white cohorts were more likely to receive PIMs and more likely to return within 30 days. However, race was not associated with ED revisits nor hospital admissions. Furthermore, literature suggests older age may be a stronger predictor of ED revisits than receiving a PIMs, but we did not find this to be the case.”
Notably, patients who did not receive potentially inappropriate medications had more comorbidities, which was associated with an increased risk of ED revisits and hospital admissions.
However, according to the researchers, these clinical features may not paint the full picture and that other undetected clinical variable may have an impact on the results seen throughout the study.
“If clinical features do not fully explain why fewer patients who received PIM prescriptions revisit the ED or become hospitalized, we may have to look at PIMs from a different angle and reassess our own understanding of their hazards,” noted the researchers. “Growing evidence suggests ED visits and hospitalization rates are associated with the total number of medications prescribed, not PIMs specifically, although we did not find that to be the case.”
Reference
Hammouda N, Vargas-Torres C, Doucette J, Hwang U. Geriatric emergency department revisits after discharge with Potentially Inappropriate Medications: A retrospective cohort study. Am J Emerg Med. 2021;44:148-156. doi: 10.1016/j.ajem.2021.02.004
Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as Men Age
March 28th 2024A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary invasive melanoma following an initial primary melanoma, suggesting the benefits of increased surveillance in these patients.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More